Personalized medicine could see big boost after Wisconsin designated a tech hub
The designation means the state can compete for $40 million to $70 million to expand its biohealth industry.
Source: madison.com
📰 Exact Sciences News
Page 26 - Exact Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Exact Sciences. Real-time updates on events, politics, business and more.
Exact Sciences Co. (NASDAQ:EXAS) Receives $96.18 Average Price Target from Analysts
Shares of Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) have received a consensus rating of “Moderate Buy” from the fifteen analysts that are covering the stock, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and eleven have given a buy recommendation to the company. The average 12-month price […]
United States Brian Baranick Piper Sandler James Edward Doyle Victory Capital Management Inc News Ratings For Exact Sciences Daily
Source: tickerreport.com
Next-Generation Cologuard Improves Colorectal Cancer Detection, False Positive Rates in BLUE-C
Thomas F. Imperiale, MD, discusses the pivotal findings showing improvements to the prior iteration of Cologuard, as well as bettered sensitivity and specificty relative to fecal immunochemical tests.
British Columbia Thomasf Imperiale Sciences Corp Indiana University Medical Center American College Of Gastroenterology American College
Source: hcplive.com
Potentially Unnecessary CRC Screening in Older Adults: Study
A study found that adults with limited life expectancy often undergo colon cancer screening, raising concerns about inappropriate screening.
United States University Of Texas Southwestern Medical Center Chong Liu National Institutes Of Health Division Of Digestive Po Hong Liu
Source: medscape.com
MDxHealth : émission d'actions pour l'acquisition du test Oncotype DX GPS auprès de Genomic Health
Emission par MDxHealth d'un total de 2.500.000 nouvelles actions...
Sciences Corporation Genomic Health Genomic Prostate Score De Health Inc Genomic Prostate Score Exact Sciences
Source: boursier.com
Next-Generation Cologuard® Test Demonstrates High Sensitivity and Specificity in Pivotal BLUE-C Study, Significantly Outperforming Fecal Immunochemical Testing (FIT) for Cancer and Precancer Detection
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced late-breaking data from the...
Source: prnewswire.com
Two Multitarget Stool Tests Show Promise for CRC Screening
Two noninvasive tests in development, one measuring RNA and the other DNA, show high sensitivity for detection of colorectal cancer.
Source: medscape.com
Exact Sciences Advances Early Cancer Detection and Precision Oncology Programs with Data Presentations at ESMO 2023 Annual Congress
MADISON, Wis., Oct. 20, 2023 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, tod...
Source: businessinsider.com
Piper Sandler Cuts Exact Sciences (NASDAQ:EXAS) Price Target to $80.00
Exact Sciences (NASDAQ:EXAS – Free Report) had its target price decreased by Piper Sandler from $90.00 to $80.00 in a research note issued to investors on Monday, Benzinga reports. Piper Sandler currently has an overweight rating on the medical research company’s stock. A number of other research firms have also weighed in on EXAS. The […]
Source: wkrb13.com
Exact Sciences Advances Early Cancer Detection and Precision Oncology Programs with Data Presentations at ESMO 2023 Annual Congress
MADISON, Wis., Oct. 20, 2023 /PRNewswire/ -- Exact Sciences Corp. , a leading provider of cancer screening and diagnostic tests, today announced it will present new data supporting the companys...
Federico Maiardi Catherine Marinac Megan Jones Jack Hirschfield Nickolas Papadopoulos Elizabeth Odonnell
Source: marketscreener.com